Autologous peripheral blood stem cell combined with high-dose arterial chemotherapy for advanced gastric cancer

World Chinese Journal of Digestology

Volumn 10, Issue 12, 2002, Pages 1408-1411

  Zhu, Jin Shui ^a   Zhu, Li ^a   Wang, Long ^a   Zhuang, Qi Xin ^a   Hu, Bin ^a   Da, Wei ^a   Chen, Wei Xiong ^a   Chen, Guo Qiang ^b   Ma, Ji Qing ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b China South Gene Center   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOXORUBICIN; ETOPOSIDE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASCITES; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; MALE; SIDE EFFECT; STOMACH CANCER; TUMOR VOLUME;

EID: 0036913549     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Clausen J, Petzer AL, Vergeiner B, Enk M, Stauder R, Gastl G, Gunsilius E. Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation. J Hematother Stem Cell Res 2001;10:513-521
2. Mukai M, Bohgaki T, Kondo M, Notoya A, Kohno M. Changes in the T-helper cell 1/T-helper cell 2 balance of peripheral T-helper cells after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Ann Hematol 2001;80: 715-721
3. Bont ES, Guikema JE, Scherpen F, Meeuwsen T, Kamps WA, Vellenga E, Bos NA. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma. Cancer Res 2001;61:7654-7659
4. Fukuno K, Tsurumi H, Yamada T, Oyama M, Moriwaki H. Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation. Int J Hematol 2001;73:262-265
5. Sanz GF, Saavedra S, Jimenez C, Senent L, Cervera J, Planelles D, Bolufer P, Larrea L, Martin G, Martinez J, Jarque I, Moscardo F, Plume G, Andreu R, de la Rubia J, Barragan E, Solves P, Soler MA, Sanz MA. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: Results in nine patients from a single institution. Bone Marrow Transplant 2001;27:693-701
6. Butch AW, Badros A, Desikan KR, Munshi NC. Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma. Bone Marrow Transplant 2001;27:663-666
7. Park KU, Kim SH, Suh C, Kim S, Lee SJ, Park JS, Cho HJ, Kim KW, Lee K, Kim HJ, Park J, Joo Min Y, Kim JG, Kim T, Lee JH, Kim SB, Kim SW, Lee KH, Lee JS, Kim WK, Park CJ, Chi HS. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products. Am J Hematol 2001;67:42-47
8. Gokmen E, Bachier C, Raaphorst FM, Muller T, Armstrong D, Lemaistre CF, Teale JM. Ex vivo-expanded hematopoietic cell graft recipients exhibit T cell repertoire diversity similar to that seen after conventional stem cell transplants. J Hematother Stem Cell Res 2001;10:53-66
9. Fujii H, Iwai T, Ueda Y, Nakagawa H. [Development of Hodgkin's disease four years after autologous peripheral blood stem cell transplantation for multiple myeloma,] Rinsho Ketsueki 2000;41:1267-1272
10. Meloni G, Proia A, Guerrisi V, Cordone I, De Cuia R, Fenu S, Mauro FR, Pescarmona E, Reato G, Mandelli F. Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation. Ann Oncol 2000;11:1493-1495
11. Sezer O, Eucker J, Bauhuis C, Schweigert M, Luftner D, Kalus U, Spath-Schwalbe E, Arnold R, Possinger K. Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation. Ann Hematol 2000;79:627-630
12. Matsuzaki A, Eguchi H, Ikuno Y, Ayukawa H, Yanai F, Ishii E, Sugimoto T, Inada H, Anami K, Nibu K, Hara T, Miyazaki S, Okamura J. Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: A report from the Kyushu-Yamaguchi Children's Cancer Study group in Japan. Pediatr Hematol Oncol 2000;17:623-634
13. Sefcick A, Byrne JL, Russell NH. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in lymphoma without blood product support. Bone Marrow Transplant 2000;26:1140-1141
14. Scheulen ME, Hilger RA, Oberhoff C, Casper J, Freund M, Josten KM, Bornhauser M, Ehninger G, Berdel WE, Baumgart J, Harstrick A, Bojko P, Wolf HH, Schindler AE, Seeber S. Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies. Clin Cancer Res 2000;6:4209-4216
15. Ishii E, Honda K, Nakagawa A, Urago K, Oshima K. Primary CD30/Ki-1 positive anaplastic large cell lymphoma of skeletal muscle with der(17)t(1;17)(q11,p11). Cancer Genet Cytogenet 2000;122: 116-120
16. Jillella AP, Kallab AM, Kutlar A. Autoimmune thrombocytopenia following autologous hematopoietic cell transplantation: Review of literature and treatment options. Bone Marrow Transplant 2000;26:925-927
17. Sezer O, Niemoller K, Jakob C, Langelotz C, Eucker J, Possinger K. Novel approaches to the treatment of primary amyloidosis. Expert Opin Investig Drugs 2000;9:2343-2350
18. Waldmann V, Goldschmidt H, Jackel A, Deichmann M, Hegenbart U, Hartschuh W, Ho A, Naher H. Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation. Br J Dermatol 2000;143:837-839
19. Kajiume T, Yoshimi S, Nagita A, Kobayashi K, Kataoka N. Application of nitric oxide for a case of veno-occlusive disease after peripheral blood stem cell transplantation. Pediatr Hematol Oncol 2000;17:601-604
20. Dreger P, Viehmann K, von Neuhoff N, Kruss D, Glass B, Kneba M, Mitsky P, Jopp P, Rautenberg P, Mills B, Schmitz N. A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia. Exp Hematol 2000; 28:1187-1196
21. Noguchi M, Sakamoto N, Okumura K, Sato N, Yamada K, Isobe Y, Kato A, Oshimi K. [CD8-positive diffuse large B-cell lymphoma]. Rinsho Ketsueki 2000;41:591-595
22. Bhatia S, Abonour R, Porcu P, Seshadri R, Nichols CR, Cornetta K, Einhorn LH. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 2000;18:3346-3351
23. Luppi M, Barozzi P, Schulz TF, Trovato R, Donelli A, Narni F, Sheldon J, Marasca R, Torelli G. Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood 2000;96:2355-2357
24. Yamane T, Hino M, Ohta K, Kunter U, Schenk F, Franzke A. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma. Gan To Kagaku Yoho 2000;27:1547-1555
25. Schenkein DP, Koc Y, Alcindor T, Ohta K, Schenk F. Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor. Biol Blood Marrow Transplant 2000;6:448-455
26. Schrader AJ, Probst-Kepper M, Grosse J, Kunter U, Schenk F, Franzke A, Atzpodien J, Buer J. Molecular and prognostic classification of advanced melanoma: A multi-marker microcontamination assay of peripheral blood stem cells. Melanoma Res 2000;10:355-362
27. Despres D, Flohr T, Uppenkamp M, Baldus M, Hoffmann M, Huber C, Derigs HG. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device. J Hematother Stem Cell Res 2000;9:557-564
28. Chauncey TR, Gooley TA, Lloid ME, Schubert MM, Lilleby K, Holmberg L, Bensinger WI. Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Am J Clin Oncol 2000; 23:406-411
29. Nishio M, Koizumi K, Endo T, Takashima H, Haseyama Y, Fujimoto K, Yamamoto S, Koike T, Sawada K. [Effective chemotherapy with docetaxel in a patient with breast cancer who had progressed after high-dose chemotherapy with autologous peripheral blood stem cell transplantation (APBSCT)]. Gan To Kagaku Ryoho 2000;27:1421-1424
30. Celebi H, Akan H, Akcaglayan E, Ustun C, Arat M. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant 2000;26:211-214
31. Ozet A, Yavuz AA, Ozturk B, Komurcu S, Arpaci F, Tuvay E, Tezcan Y. Recurrent spontaneous pneumothorax following high-dose chemotherapy in a patient with non-seminomatous testicular cancer with pulmonary metastases. Tumori 2000;86:253-255
32. Cockerham MB, Weinberger BB, Lerchie SB. Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation. Ann Pharmacother 2000;34:300-303
33. Diez-Martin JL, Buno I, Llamas P, Gosalvez J, Lopez-Fernandez C, Polo N, Regidor C. Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests. Cancer Detect Prev 2000;24:169-172
34. Sezer O, Eucker J, Jakob C, Ozturk B, Komurcu S, Arpaci F. Diagnosis and treatment of AL amyloidosis. Clin Nephrol 2000; 53:417-423
35. Nishio M, Koizumi K, Endo T, Ozturk B, Komurcu S, Arpaci F, Tuvay E. Effective high-dose chemotherapy combined with CD34+-selected autologous peripheral blood stem cell transplantation in a patient with cutaneous CD30-negative large T cell lymphoma. Bone Marrow Transplant 2000;25:1315-1317
36. Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, Berenson JR, Collins RH, Koup RA. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000;355:1875-1881
37. Satoh S, Saito T, Akiba J, Arpaci F, Tuvay E. Burkitt's lymphoma occurring as a primary lymphomatous effusion. Rinsho Ketsueki 2000;41:329-333
38. Yanovich S, Mitsky P, Cornetta K, Endo T, Ozturk B, Komurcu S. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: Results of a prospective randomized multicenter clinical trial. Bone Marrow Transplant 2000;25:1165-1174
39. Donato ML, Champlin RE, Wharton JT, Bodurka-Bevers D, Gershenson D. Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer. Eur J Gynaecol Oncol 2000;21:241-244
40. Shimazaki C, Inaba T, Okano A, Hatsuse M, Takahashi R, Hirai H, Sudo Y, Ashihara E, Adachi Y, Murakami S, Saigo K, Tsuda H, Fujita N, Nakagawa M. Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): Comparison of CD5+ with CD5-B-LAHS. Intern Med 2001;40:878-882
41. Muroi K, Suzuki T, Amemiya Y, Yoshida M, Kawano C, Kuribara R, Otsuki T, Izumi T, Tomizuka H, Komatsu N, Imagawa S, Hatake K, Miura Y, Ozawa K. Autologous peripheral blood stem cell transplantation for adults with B-lineage acute lymphoblastic leukemia: A pilot study. Leuk Lymphoma 2000;38:103-111
42. Singh RK, Varney ML, Ino K, Vose JM, Bierman PJ, Talmadge JE. Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients. Exp Hematol 2000;28:499-507
43. Yoshimura C, Nomura S, Katsura K, Yamaguchi K, Fukuhara S. Thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation. Vox Sang 2000;78:106-112
44. Kuhne T, Staehelin F, Avoledo P, Tichelli A, Passweg J, Imbach P, Gratwohl A. [Single and double high-dose chemotherapy with autologous stem cell transplantation in children with advanced solid tumors: First experiences] Schweiz Med Wochenschr 2000;130:419-425
45. Demirer T, Ilhan O, Mandel NM, Arat M, Gunel N, Celebi H, Ustun C, Akan H, Demirer S, Aydintug S, Uysal A, Koc H. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies. Bone Marrow Transplant 2000;25:697-703
46. Sasaki M, Matsue K, Takeuchi M, Mitome M, Hirose Y. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation. Int J Hematol 2000;71:75-78
47. Dix SP, Geller RB. High-dose chemotherapy with autologous stem cell rescue in the outpatient setting. Oncology (Huntingt) 2000;14:171-185
48. Saigo K, Sugimoto T, Matsuo M, Narita H, Ryo R, Kumagai S. [G-CSF administration following autologous peripheral blood stem cell transplantation-the effect of G-CSF level on neutrophil recovery]. Gan To Kagaku Ryoho 2000;27:437-442
49. Kyle RA. Management of patients with multiple myeloma: Emphasizing the role of high-dose therapy. Clin Lymphoma 2001;2: 21-28
50. Sawada M, Tsurumi H, Hara T, Goto H, Yamada T, Oyama M, Moriwaki H. Graft failure of autologous peripheral blood stem cell transplantation due to acute metabolic acidosis associated with total parenteral nutrition in a patient with relapsed breast cancer. Acta Haematol 2000;102:157-159
51. Mazza P, Amurri B, Palazzo G, Prudenzano A, Pricolo G, Stani L. Fludarabine containing regimen followed by autologous peripheral blood stem cell transplantation in unselected patients with acute myeloid leukemia: A single center experience. Haematologica 2000;85:222-224
52. Herget-Rosenthal S, Uppenkamp M, Beelen D, Kohl D, Kribben A. Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation. Nephron 2000;84:136-141
53. Kapur D, Dorsky D, Feingold JM, Bona RD, Edwards RL, Aslanzadeh J, Tutschka PJ, Bilgrami S. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2000;25:147-152
54. Bilgrami S, Feingold JM, Bona RD, Edwards RL, Khan AM, Rodriguez-Pinero F, Khan IA, Kazierad D, Clive J, Tutschka PJ. Dose-intense paclitaxel, etoposide and cyclophosphamide: A safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer. Bone Marrow Transplant 2000;25:123-130
55. Jost LM, Honegger HP, Stahel RA. High-dose chemotherapy with autologous bone marrow transplantation: 11 Years' experience in Zurich. Schweiz Med Wochenschr 2000;130:60-69
56. Bogart JA, Ungureanu C, Ryu S. Hematologic toxic reaction to radiation therapy adjuvant to autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin disease. Radiology 2000;214:421-425
57. Fanfulla F, Pedrazzoli P, Da Prada GA, Bruschi C, Dacosto E, Zambelli A, della Cuna GR, Rampulla C. Pulmonary function and complications following chemotherapy and stem cell support in breast cancer. Eur Respir J 2000;15:56-61
58. Sezer O, Eucker J, Schmid P, Possinger K. New therapeutic approaches in primary systemic AL amyloidosis. Ann Hematol 2000;79:1-6
59. Nagahama M, Nomura S, Katsura K, Ozaki Y, Yoshimura C, Kagawa H, Fukuhara S. Serum levels of soluble CD30 in autologous peripheral blood stem cell transplantation. J Cancer Res Clin Oncol 2000;126:101-106
60. Tribalto M, Amadori S, Cudillo L, Caravita T, Del Poeta G, Meloni G, Avvisati G, Petrucci MT, Pulsoni A, Leone G, Sica S, Martelli M, Tabilio A, Fioritoni G, Majolino I, Mandelli F. Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: An Italian Multicenter Study. Haematologica 2000;85:52-58